Last updated on February 2019

A Study to Investigate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected Participants


Brief description of study

This study is sponsor-open, investigator-blinded, participant-blinded, randomized, placebo-controlled, single-ascending dose (SAD) and multiple-ascending dose (MAD) study that will evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of RO7049389 following oral administration in healthy volunteers and chronic HBV infected participants. The effect of food on the PK of RO7049389 and the effect of multiple dosing of RO7049389 on the PK of a single oral microdose of midazolam will be evaluated. The study will be conducted in two parts: Part 1 (1a [SAD cohort], 1b [Food-effect SAD cohort], 1c [MAD Cohort]) in healthy volunteers and Part 2 (Proof of mechanism [POM]) in chronic HBV infected participants.

Clinical Study Identifier: NCT02952924

Contact Investigators or Research Sites near you

Start Over

Reference Study ID Number: YP39364 ...

Royal Melbourne Hospital
Parkville, Australia
1.71miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.